Dirk Bredenbröker Selected Research

omega-Chloroacetophenone (Mace)

9/2013

Cardiovascular safety in patients receiving roflumilast for the treatment of COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dirk Bredenbröker Research Topics

Disease

9	Chronic Obstructive Pulmonary Disease (COPD) 01/2014 - 08/2005
3	Asthma (Bronchial Asthma) 10/2011 - 08/2005
2	Chronic Bronchitis 01/2014 - 01/2011
2	Inflammation (Inflammations) 10/2011 - 05/2006
1	Dyspnea (Shortness of Breath) 01/2014
1	Myocardial Infarction 09/2013
1	Stroke (Strokes) 09/2013
1	Respiratory Hypersensitivity 10/2011
1	Cough 01/2011
1	Emphysema 01/2011
1	Necrosis 12/2007
1	Lung Diseases (Lung Disease) 08/2005

Drug/Important Bio-Agent (IBA)

11	RoflumilastIBA 01/2014 - 08/2005
5	Phosphodiesterase 4 InhibitorsIBA 09/2013 - 05/2006
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2014 - 08/2005
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014 - 05/2006
2	AllergensIBA 10/2011 - 08/2005
1	Muscarinic AntagonistsIBA 01/2014
1	omega-Chloroacetophenone (Mace)IBA 09/2013
1	GoldIBA 05/2013
1	Pharmaceutical PreparationsIBA 05/2013
1	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2007
1	Interleukin-8 (Interleukin 8)IBA 12/2007
1	Eosinophil Cationic ProteinIBA 12/2007
1	Bronchodilator Agents (Bronchodilators)IBA 12/2007

Therapy/Procedure

2	Therapeutics 09/2013 - 01/2011